Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 04:07 am EDT
Share
Seoulin Bioscience Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 9.2 million compared to KRW 13.42 million a year ago. Net income was KRW 57.36 million compared to KRW 6,016.83 million a year ago. Basic earnings per share from continuing operations was KRW 6.8365 compared to KRW 698.2976 a year ago. Diluted earnings per share from continuing operations was KRW 6.8365 compared to KRW 339.8707 a year ago. Basic earnings per share was KRW 6.8365 compared to KRW 702.2041 a year ago. Diluted earnings per share was KRW 6.8365 compared to KRW 342.8006 a year ago.
For the six months, sales was KRW 18.41 million compared to KRW 47.47 million a year ago. Net income was KRW 1,861.87 million compared to KRW 8,075.19 million a year ago. Basic earnings per share from continuing operations was KRW 217.7907 compared to KRW 939.5276 a year ago. Diluted earnings per share from continuing operations was KRW 217.7907 compared to KRW 572.311 a year ago. Basic earnings per share was KRW 217.7907 compared to KRW 942.4575 a year ago. Diluted earnings per share was KRW 217.7907 compared to KRW 575.2409 a year ago.
Seoulin Bioscience Co., Ltd is a Korea-based company engaged in the developing and manufacturing of basic equipment for bio research. The Company mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The company supplies its products under the brand name MyLab. It also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.